{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Supernus Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"SUPN"},"Address":{"label":"Address","value":"9715 KEY WEST AVENUE, ROCKVILLE, Maryland, 20850, United States"},"Phone":{"label":"Phone","value":"+1 301 838-2500"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.supernus.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Frank Mottola","title":"Senior VP-Quality, GMP Operations & IT"},{"name":"Jack A. Khattar","title":"President, CEO, Secretary & Director"},{"name":"Jonathan Rubin","title":"Senior VP-R&D, Chief Medical Officer"},{"name":"Padmanabh P. Bhatt","title":"Chief Scientific Officer & Senior Vice President"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}